June 20th 2024
This month's Legal Eagle column explores if a dermatologist can be sued for charging a fee for providing medical records in a lawsuit.
June 8th 2024
Can I be sued for off-label use within standard of care?
May 10th 2018Is it misuse to use medication for off-label uses? A patient sues after developing facial pain and other symptoms associated with the use of a topical for scabies. Is this physician guilty of practicing medicine outside the standard of care?
Key steps to avoid a malpractice lawsuit
May 10th 2018Aesthetic practices that provide laser and light-based therapies should be cognizant of legal issues that may affect the practice. “Legal issues arise in all facets of medicine. However, in cosmetics, the patient’s expectation of outcomes is often in conflict with that of the clinician. There is a heightened potential for patient dissatisfaction that can ultimately lead to legal action,” says Dr. Mathew Avram.
Medicare, coding and reimbursement challenges that lie ahead
February 19th 2018Speaking at the American Academy of Dermatology annual meeting in February, Dr. Brett Coldiron described challenges dermatologists should be prepared for this year, including Medicare payment reductions, insurers' cost-saving strategies and practice consolidations.
5 great books for holiday ‘you time’
The holidays offer some time to unwind and recalibrate before the calendar flips to the new year. If you enjoy reading, here are five recommendations we hope will resonate with you, inspire you, and maybe move you into the New Year with just a little more insight and enthusiasm.
Venture capital and the future of dermatology: A reassessment
Dr. Norman Levine offers bits of advice for those considering this type of change in your practice for those considering selling their practices to venture capital-backed enterprises based on his experience with one such company.
A different perspective on venture capital and the future of dermatology
If we do not evolve ... we will soon be an extinct species of medical practitioner, Dermatology Times Editorial Advisor says in his column this month. He shares his experience and considerations with negotiating the sale of his practice to a venture capital backed firm.